These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 28483344)

  • 1. The Exceptional Vulnerability of Humans to Alzheimer's Disease.
    Walker LC; Jucker M
    Trends Mol Med; 2017 Jun; 23(6):534-545. PubMed ID: 28483344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative pathobiology of β-amyloid and the unique susceptibility of humans to Alzheimer's disease.
    Rosen RF; Tomidokoro Y; Farberg AS; Dooyema J; Ciliax B; Preuss TM; Neubert TA; Ghiso JA; LeVine H; Walker LC
    Neurobiol Aging; 2016 Aug; 44():185-196. PubMed ID: 27318146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonhuman primate models of Alzheimer-like cerebral proteopathy.
    Heuer E; Rosen RF; Cintron A; Walker LC
    Curr Pharm Des; 2012; 18(8):1159-69. PubMed ID: 22288403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prion-like mechanisms in Alzheimer disease.
    Walker LC
    Handb Clin Neurol; 2018; 153():303-319. PubMed ID: 29887142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aβ seeds and prions: How close the fit?
    Rasmussen J; Jucker M; Walker LC
    Prion; 2017 Jul; 11(4):215-225. PubMed ID: 28657440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A standard model of Alzheimer's disease?
    Walker LC; Lynn DG; Chernoff YO
    Prion; 2018; 12(5-6):261-265. PubMed ID: 30220236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral amyloid-beta protein accumulation with aging in cotton-top tamarins: a model of early Alzheimer's disease?
    Lemere CA; Oh J; Stanish HA; Peng Y; Pepivani I; Fagan AM; Yamaguchi H; Westmoreland SV; Mansfield KG
    Rejuvenation Res; 2008 Apr; 11(2):321-32. PubMed ID: 18341428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Function and toxicity of amyloid beta and recent therapeutic interventions targeting amyloid beta in Alzheimer's disease.
    Rajasekhar K; Chakrabarti M; Govindaraju T
    Chem Commun (Camb); 2015 Sep; 51(70):13434-50. PubMed ID: 26247608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease.
    Jackson RJ; Rudinskiy N; Herrmann AG; Croft S; Kim JM; Petrova V; Ramos-Rodriguez JJ; Pitstick R; Wegmann S; Garcia-Alloza M; Carlson GA; Hyman BT; Spires-Jones TL
    Eur J Neurosci; 2016 Dec; 44(12):3056-3066. PubMed ID: 27748574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The participation of insulin-like growth factor-binding protein 3 released by astrocytes in the pathology of Alzheimer's disease.
    Watanabe K; Uemura K; Asada M; Maesako M; Akiyama H; Shimohama S; Takahashi R; Kinoshita A
    Mol Brain; 2015 Dec; 8(1):82. PubMed ID: 26637371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of proteins related neurodegeneration in autopsy brains of the aged].
    Zhu M; Meng X; Wang L; Hu Y; Zhang H; Han Z
    Zhonghua Bing Li Xue Za Zhi; 2014 Oct; 43(10):651-6. PubMed ID: 25567589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging prospects for the disease-modifying treatment of Alzheimer's disease.
    Walker LC; Ibegbu CC; Todd CW; Robinson HL; Jucker M; LeVine H; Gandy S
    Biochem Pharmacol; 2005 Apr; 69(7):1001-8. PubMed ID: 15763538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurofibrillary Tangles of Aβx-40 in Alzheimer's Disease Brains.
    Lacosta AM; Insua D; Badi H; Pesini P; Sarasa M
    J Alzheimers Dis; 2017; 58(3):661-667. PubMed ID: 28453491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetically augmenting tau levels does not modulate the onset or progression of Abeta pathology in transgenic mice.
    Oddo S; Caccamo A; Cheng D; Jouleh B; Torp R; LaFerla FM
    J Neurochem; 2007 Aug; 102(4):1053-63. PubMed ID: 17472708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The pathophysiology of Alzheimer's disease with special reference to "amyloid cascade hypothesis"].
    Tamaoka A
    Rinsho Byori; 2013 Nov; 61(11):1060-9. PubMed ID: 24450113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein aggregation in Alzheimer's disease: Aβ and τ and their potential roles in the pathogenesis of AD.
    Thal DR; Fändrich M
    Acta Neuropathol; 2015 Feb; 129(2):163-5. PubMed ID: 25600324
    [No Abstract]   [Full Text] [Related]  

  • 18. Progression of Alzheimer's disease, tau propagation, and its modifiable risk factors.
    Takeda S
    Neurosci Res; 2019 Apr; 141():36-42. PubMed ID: 30120962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of HMG-CoA reductase inhibitors on beta-amyloid peptide levels: implications for Alzheimer's disease.
    Höglund K; Blennow K
    CNS Drugs; 2007; 21(6):449-62. PubMed ID: 17521225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plaque formation and the intraneuronal accumulation of β-amyloid in Alzheimer's disease.
    Takahashi RH; Nagao T; Gouras GK
    Pathol Int; 2017 Apr; 67(4):185-193. PubMed ID: 28261941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.